Skip to main content
. Author manuscript; available in PMC: 2009 Apr 7.
Published in final edited form as: Int J Cancer. 2009 Feb 1;124(3):664–669. doi: 10.1002/ijc.24007

Table 2.

Urinary endoglin normalized to total urinary protein (TP) as a marker for prostate cancer in men at increased risk for prostate cancer (abnormal PSA &/or DRE)

Sensitivity Specificity
Urinary Endoglin/TP Cutoff
% 95% CI % 95% CI
14.8 34.3 (23.1 – 46.9) 93.7 (79.1 – 99.2)
8.9 53.7 (41.1 – 66.0) 84.3 (67.2 – 94.7)
4.0 73.1 (60.9 – 83.2) 62.5 (43.6 – 78.9)
3.1 80.6 (69.1 – 89.2) 50.0 (31.8 – 68.1)
1.9 85.0 (74.2 – 92.6) 43.8 (26.3 – 62.3)